Shopping Cart
- Remove All
- Your shopping cart is currently empty
GLL 398 is an orally active and selective degrader of estrogen receptor with an IC50 of 1.14 nM. GLL 398 blocks tumor growth in xenograft breast cancer models.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | Backorder | |
5 mg | $437 | Backorder | |
10 mg | $655 | Backorder | |
25 mg | $1,178 | Backorder | |
50 mg | $1,768 | Backorder | |
100 mg | $2,652 | Backorder | |
200 mg | $3,978 | Backorder | |
1 mL x 10 mM (in DMSO) | $447 | Backorder |
Description | GLL 398 is an orally active and selective degrader of estrogen receptor with an IC50 of 1.14 nM. GLL 398 blocks tumor growth in xenograft breast cancer models. |
In vitro | GLL398 exhibits a strong dose-dependent binding profile for the estrogen receptor with a Y537S point mutation with an IC50 of 29.5 nM[1]. |
Molecular Weight | 398.26 |
Formula | C25H23BO4 |
Cas No. | 2077980-80-2 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 245 mg/mL (615.18 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.